fenarimol has been researched along with ly 56110 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davenport, JD; Hirsch, KS; Jones, CD; Kress, TJ; Taylor, HM; Weaver, D | 1 |
Abbott, MJ; Alexander, PW; Armstrong, T; Berven, B; Best, WM; Botero, A; Chaplin, JH; Charman, SA; Chatelain, E; Keenan, M; Kerfoot, M; Khong, A; McManus, JD; Morizzi, J; Nguyen, T; Ryan, E; Scandale, I; Thompson, RA; von Geldern, TW; Wang, SZ; White, KL | 1 |
2 other study(ies) available for fenarimol and ly 56110
Article | Year |
---|---|
Aromatase inhibition by 5-substituted pyrimidines and dihydropyrimidines.
Topics: Animals; Aromatase Inhibitors; Chemical Phenomena; Chemistry; Female; Microsomes; Ovary; Pyrimidines; Rats; Structure-Activity Relationship | 1987 |
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
Topics: Animals; Cell Line; Chagas Disease; Disease Models, Animal; Gas Chromatography-Mass Spectrometry; Inhibitory Concentration 50; Male; Mice; Nuclear Magnetic Resonance, Biomolecular; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2012 |